Search results for “Clobetasol propionate” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 305 patents, we discovered top 56 key players by total patent application. Galderma International SAS, Galderma Research & Development SNC, Dow Pharmaceutical Sciences, Inc. are dominant in this area. They take 50.82% of the total patent filing.
Galderma International SAS
France
Patent: 120
Galderma Research & Development SNC
France
Patent: 19
Dow Pharmaceutical Sciences, Inc.
California, United States
Patent: 16
Dermalogix Partners, Inc.
New Jersey, United States
Patent: 15
Nexmed Holding AG
Switzerland
Patent: 13
Sinomune Pharmaceutical Co., Ltd
Jiangsu Sheng, China
Patent: 12
Centro de Investigacion y Desarrollo de Medicamentos CIDEM
United States
Patent: 11
Senju-USA, Inc.
California, United States
Patent: 11
Wakamoto Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 9
Abigo Medical AB
Sweden
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 40 patents applied in the last 5 years. We discover 17 most active companies in this area. The fast-growing Henan Lihua Pharmaceutical Co. Ltd., Northwest A&F University, Galderma Research & Development SNC take 15.00% of patent filing during this period.
Henan Lihua Pharmaceutical Co. Ltd.
Henan Sheng, China
Patent: 2
Northwest A&F University
Shaanxi Sheng, China
Patent: 2
Galderma Research & Development SNC
France
Patent: 2
Jiangsu Chenpai Bond Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Sinomune Pharmaceutical Co., Ltd
Jiangsu Sheng, China
Patent: 2
Anhui Yunxun Biotechnology Co., Ltd.
Anhui Sheng, China
Patent: 1
Anhui Public Inspection Research Institute Co., Ltd.
Anhui Sheng, China
Patent: 1
Yaodi Biotechnology Xuzhou Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Jiangnan University
Jiangsu Sheng, China
Patent: 1
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 40 patents in last 5 years, we discover 14 new entrants. Henan Lihua Pharmaceutical Co. Ltd., Jiangsu Chenpai Bond Pharmaceutical Co., Ltd., Anhui Yunxun Biotechnology Co., Ltd. are the most active new entrants in this area.
Henan Lihua Pharmaceutical Co. Ltd.
Henan Sheng, China
Patent: 2
Jiangsu Chenpai Bond Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Anhui Yunxun Biotechnology Co., Ltd.
Anhui Sheng, China
Patent: 1
Anhui Public Inspection Research Institute Co., Ltd.
Anhui Sheng, China
Patent: 1
Yaodi Biotechnology Xuzhou Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Jiangnan University
Jiangsu Sheng, China
Patent: 1
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Kindeva Drug Delivery LP
Minnesota, United States
Patent: 1
Cmpd Licensing LLC
United States
Patent: 1
Jiangsu Farever Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 19 patents, we discovered top 5 universities and scientific research institutions by total patent application. Northwest A&F University, The Second Military Medical University, Jiangnan University are dominant in this area. They take 68.42% of the total patent filing.
Northwest A&F University
Shaanxi Sheng, China
Patent: 8
The Second Military Medical University
Shanghai Shi, China
Patent: 3
Jiangnan University
Jiangsu Sheng, China
Patent: 1
Universidade Federal de Ouro Preto
Acre, Brazil
Patent: 1
Guangxi Minzu University
Guangxi Zhuangzu Zizhiqu, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: